Results 31 to 40 of about 332,661 (303)

Beta herpes viruses in patients with cutaneous graft-versus-host disease

Журнал инфектологии, 2015
Graft-versus-host disease is a major complication of allogenic bone marrow transplantation. Beta herpes viruses’ role in pathogenesis and prognosis of graft-versus-host disease is significant.
V. V. Baykov, I. S. Moiseev, A. Yu. Petrova, E. V. Lisukova, I. E. Belousova, I. O. Smirnova, I. N. Telichko   +6 more
doaj   +1 more source

The histologic grading systems for intestinal acute graft-versus-host disease used in this study. [PDF]

, 2021
The histologic grading systems for intestinal acute graft-versus-host disease used in this study.
Ernst Holler (136435), Daniela Weber (3470189), Katrin Hippe (11337273), Isabelle Ries (11337279), Helmut Neumann (391222), Arne Kandulski (11337282), Mario Schindeldecker (11337285), Andreas Kreft (385758), Maike Büttner-Herold (5280527), Eva Maria Wagner-Drouet (11337276)   +9 more
core   +1 more source

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

Haematologica, 2016
We previously reported that bone marrow grafts from matched sibling donors resulted in best graft-versus-host disease-free, relapse-free survival at 1-year post allogeneic hematopoietic cell transplantation.
Rohtesh S. Mehta, Regis Peffault de Latour, Todd E DeFor, Marie Robin, Aleksandr Lazaryan, Aliénor Xhaard, Nelli Bejanyan, Flore Sicre de Fontbrune, Mukta Arora, Claudio G. Brunstein, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan, Gerard Socie, Shernan G. Holtan   +14 more
doaj   +1 more source

Adoptive Immunotherapy in Chimeras with Donor Lymphocytes [PDF]

, 2003
Allogeneic stem cell transplantation has a well-defined indication in the treatment of hematological malignancies. The beneficial immune effect of allogeneic marrow transplantation has long been known, but only recently have methods been developed to ...
Kolb, Hans-Jochem, Roskrow, Marie, Guenther, Wolfgang, Schmid, Christoph, Ledderose, Georg, Weber, Martin, Chen, Xiao, Schleuning, Michael, Woiciechowski, Anja   +8 more
core   +1 more source

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

Haematologica, 2015
Ocular chronic graft-versus-host disease is one of the most bothersome common complications following allogeneic hematopoietic stem cell transplantation.
Lauren M. Curtis, Manuel B. Datiles, Seth M. Steinberg, Sandra A. Mitchell, Rachel J. Bishop, Edward W. Cowen, Jacqueline Mays, John M. McCarty, Zoya Kuzmina, Filip Pirsl, Daniel H. Fowler, Ronald E. Gress, Steven Z. Pavletic   +12 more
doaj   +1 more source

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups

Haematologica, 2016
Graft-versus-host disease-free relapse-free survival, which is defined as the absence of grade III–IV acute graft-versus-host disease, systemically treated chronic graft-versus-host disease, relapse, and death, is a novel, meaningful composite end point ...
Yoshihiro Inamoto, Fumihiko Kimura, Junya Kanda, Junichi Sugita, Kazuhiro Ikegame, Hideki Nakasone, Yasuhito Nannya, Naoyuki Uchida, Takahiro Fukuda, Kosuke Yoshioka, Yukiyasu Ozawa, Ichiro Kawano, Yoshiko Atsuta, Koji Kato, Tatsuo Ichinohe, Masami Inoue, Takanori Teshima   +16 more
doaj   +1 more source

Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern [PDF]

Anais Brasileiros de Dermatologia, 2013
Graft-versus-host disease is observed mainly in recipients of hematopoietic cell transplantation and is expressed by cutaneous or systemic signals and symptoms. Graft-versus-host disease is clinically classified as acute or chronic.
Luiza Vasconcelos, Erica Cristina Vieira, Eliana Maria Minicucci, Ana Gabriela Salvio, Mair Pedro de Souza, Mariangela Esther Alencar Marques, Silvio Alencar Marques   +6 more
doaj   +1 more source

Graft versus host disease in oncology nursing practice [PDF]

, 2014
INTRODUCTION: \ud \ud Gastrointestinal graft-versus-host disease (GI-GvHD) is extremely debilitating and is multifactorial in its causative factors, management and treatment.
Christensen, Martin, Lieow, Yuuki, Christensen, Martin (R19257)   +2 more
core   +1 more source

Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

Haematologica, 2017
Composite endpoints that not only encompass mortality and relapse, but other critical post-transplant events such as graft-versus-host disease, are being increasingly utilized to quantify survival without significant morbidity after allogeneic blood or ...
Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Javier Bolaños-Meade, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, Ivana Gojo, B. Douglas Smith, Maria P. Bettinotti, William H. Matsui, Amy E. Dezern, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Douglas E. Gladstone, Lode J. Swinnen, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik   +24 more
doaj   +1 more source

Human Mesenchymal Stem Cell Therapy for Acute Graft Versus Host Disease [PDF]

, 2016
Acute graft versus host disease (GVHD) is the most critical complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The understanding of major histocompatibility complex (MHC) and the development of acute GVHD prophylaxis have ...
Miura, Yasuo, Yoshioka, Satoshi
core   +1 more source